...
首页> 外文期刊>Nature protocols erecipes for researchers >High-throughput assay for determining enantiomeric excess of chiral diols, amino alcohols, and amines and for direct asymmetric reaction screening
【24h】

High-throughput assay for determining enantiomeric excess of chiral diols, amino alcohols, and amines and for direct asymmetric reaction screening

机译:用于测定对映体过量的手性二醇,氨基醇和胺的高通量测定以及直接不对称反应筛选

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Determining enantiomeric excess (e.e.) in chiral compounds is key to development of chiral catalyst auxiliaries and chiral drugs. Here we describe a sensitive and robust fluorescence-based assay for determining e.e. in mixtures of enantiomers of 1,2- and 1,3-diols, chiral amines, amino alcohols, and amino-acid esters. The method is based on dynamic self-assembly of commercially available chiral amines, 2-formylphenylboronic acid, and chiral diols in acetonitrile to form fluorescent diastereomeric complexes. Each analyte enantiomer engenders a diastereomer with distinct fluorescence wavelength/intensity originating from enantiopure fluorescent ligands. In this assay, enantiomers of amines and amine derivatives assemble with diol-type ligands containing a binaphthol moiety (BINOL and VANOL), whereas diol enantiomers form complexes with the enantiopure amine-type fluorescent ligand tryptophanol. The differential fluorescence is utilized to determine the amount of each enantiomer in the mixture with an error of <1% e.e. This method enables high-throughput real-time evaluation of enantiomeric/diastereomeric excess (e.e./d.e.) and product yield of crude asymmetric reaction products. The procedure comprises high-throughput liquid dispensing of three components into 384-well plates and recording of fluorescence using an automated plate reader. The approach enables scaling up the screening of combinatorial libraries and, together with parallel synthesis, creates a robust platform for discovering chiral catalysts or auxiliaries for asymmetric transformations and chiral drug development. The procedure takes similar to 4-6 h and requires 10-20 ng of substrate per well. Our fluorescence-based assay offers distinct advantages over existing methods because it is not sensitive to the presence of common additives/impurities or unreacted/incompletely utilized reagents or catalysts.
机译:在手性化合物中测定对映体过量(例如)是手性催化剂助剂和手性药物的开发的关键。在这里,我们描述了一种基于敏感和鲁棒的荧光基测定,用于确定例如。在1,2-和1,3-二醇,手性胺,氨基醇和氨基酸酯的对映体的混合物中。该方法基于市售的手性胺,2-甲酰苯基苯甲酸和乙腈中的手性二醇的动态自组装,形成荧光不审法络合物。每个分析物对映异构体都针对源自对映荧光配体的不同荧光波长/强度的非对映异构体。在该测定中,胺和胺衍生物的对映体与含有胆碱部分(BinOl和Vanol)的二醇型配体组合,而二醇对映体与对映胺型荧光配体色氨酸色氨酸色氨酸形成络合物。利用差分荧光来确定混合物中的每个对映体的量,误差为<1%。该方法使高通量的实时评估对映体/非对映异构体过量的过量(例如,粗略反应产物的产物产率。该方法包括使用三个组分的高通量液体分配到384孔板中,并使用自动化板读卡器记录荧光。该方法使得能够缩放组合文库的筛查,以及与并行合成一起产生鲁棒平台,用于发现不对称转化和手性药物发育的手性催化剂或助剂。该程序类似于4-6小时,每孔需要10-20 ng基板。我们的荧光的测定与现有方法具有明显的优点,因为它对常见添加剂/杂质的存在不敏感或未完全/不完全使用试剂或催化剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号